BGI Australia Receives NATA Accreditation for Clinical Whole Exome Sequencing

The 460-square-metre BGI Australia genomic sequencing laboratory has been empowering Australian scientists in their cutting-edge life science research since 2017. With the latest NATA accreditation for clinical Whole Exome Sequencing (WES) the lab will expand the services to a broader community. The lab will provide genetic testing services to clinical labs, hospitals, and other partners to detect changes in the exome that contribute to rare genetic and paediatric diseases. Following the parent company BGI Group's vision Omics for All, BGI Australia will look to expand its testing scope and demonstrate its capabilities in clinical solutions, as well as seek partnerships in technology transfer to make testing more accessible to all the Australians and residents in Australia. For more information please visit BGI Australia website www.bgi-australia.com.au.